Literature DB >> 27634590

Proteomic analysis of acetaminophen-induced hepatotoxicity and identification of heme oxygenase 1 as a potential plasma biomarker of liver injury.

Yuan Gao1, Zhijun Cao1, Xi Yang1, Mohamed A Abdelmegeed2, Jinchun Sun1, Si Chen3, Richard D Beger1, Kelly Davis4, William F Salminen1, Byoung-Joon Song2, Donna L Mendrick1, Li-Rong Yu1.   

Abstract

PURPOSE: Overdose of acetaminophen (APAP) is a major cause of acute liver failure. This study was aimed to identify pathways related to hepatotoxicity and potential biomarkers of liver injury. EXPERIMENTAL
DESIGN: Rats were treated with low (100 mg/kg) and high (1250 mg/kg) doses of APAP, and liver tissues at 6 and 24 h post-treatment were analyzed using a proteomic approach of 16O/18O labeling and 2D-LC-MS/MS.
RESULTS: Molecular pathways evolved progressively from scattered and less significant perturbations to more focused and significant alterations in a dose- and time-dependent manner upon APAP treatment. Imbalanced expression of hemeoxygenase 1 (HMOX1) and biliverdin reductase A (BLVRA) was associated with hepatotoxicity. Protein abundance changes of a total of 31 proteins were uniquely correlated to liver damage, among which a dramatic increase of HMOX1 levels in plasma was observed. Liver injury-associated significant elevation of plasma HMOX1 was further validated in mice treated with APAP. CONCLUSIONS AND CLINICAL RELEVANCE: This study unveiled molecular changes associated with APAP-induced liver toxicity at the pathway levels and identified HMOX1 as a potential plasma biomarker of liver injury. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  Acetaminophen; Heme oxygenase 1 (HMOX1); Hepatotoxicity; MS

Mesh:

Substances:

Year:  2016        PMID: 27634590      PMCID: PMC5687251          DOI: 10.1002/prca.201600123

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  66 in total

1.  Biomarker potential of heme oxygenase-1 in Alzheimer's disease and mild cognitive impairment.

Authors:  Hyman M Schipper
Journal:  Biomark Med       Date:  2007-10       Impact factor: 2.851

2.  Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease.

Authors:  W Ray Kim; Steven L Flamm; Adrian M Di Bisceglie; Henry C Bodenheimer
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

3.  Plasma and urinary heme oxygenase-1 in AKI.

Authors:  Richard A Zager; Ali C M Johnson; Kirsten Becker
Journal:  J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 10.121

Review 4.  Mechanisms of acetaminophen-induced liver necrosis.

Authors:  Jack A Hinson; Dean W Roberts; Laura P James
Journal:  Handb Exp Pharmacol       Date:  2010

5.  Role of NAD(P)H:quinone oxidoreductase 1 in clofibrate-mediated hepatoprotection from acetaminophen.

Authors:  Jeffrey S Moffit; Lauren M Aleksunes; Michael J Kardas; Angela L Slitt; Curtis D Klaassen; José E Manautou
Journal:  Toxicology       Date:  2006-11-19       Impact factor: 4.221

6.  Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity.

Authors:  Mohamed A Abdelmegeed; Kwan-Hoon Moon; Chi Chen; Frank J Gonzalez; Byoung-Joon Song
Journal:  Biochem Pharmacol       Date:  2009-08-04       Impact factor: 5.858

7.  Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism.

Authors:  T Andrew Clayton; David Baker; John C Lindon; Jeremy R Everett; Jeremy K Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

8.  In vivo hepatotoxicity study of rats in comparison with in vitro hepatotoxicity screening system.

Authors:  Rie Kikkawa; Masaaki Fujikawa; Toshinori Yamamoto; Yoshimasa Hamada; Hiroshi Yamada; Ikuo Horii
Journal:  J Toxicol Sci       Date:  2006-02       Impact factor: 2.196

9.  Studies of acetaminophen and metabolites in urine and their correlations with toxicity using metabolomics.

Authors:  Jinchun Sun; Laura K Schnackenberg; Richard D Beger
Journal:  Drug Metab Lett       Date:  2009-08-01

Review 10.  Heme oxygenase-1 and acute kidney injury.

Authors:  Karl A Nath
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-01       Impact factor: 2.894

View more
  5 in total

1.  Ibuprofen alters epoxide hydrolase activity and epoxy-oxylipin metabolites associated with different metabolic pathways in murine livers.

Authors:  Shuchita Tiwari; Jun Yang; Christophe Morisseau; Blythe Durbin-Johnson; Bruce D Hammock; Aldrin V Gomes
Journal:  Sci Rep       Date:  2021-03-29       Impact factor: 4.379

Review 2.  The non-canonical effects of heme oxygenase-1, a classical fighter against oxidative stress.

Authors:  Jiajia Wu; Siyu Li; Cheng Li; Liying Cui; Jiajia Ma; Yang Hui
Journal:  Redox Biol       Date:  2021-10-20       Impact factor: 11.799

3.  Microcalorimetric Investigations of Reversible Staphylococcal Enterotoxin Unfolding.

Authors:  Susan C Berry; Odbert A Triplett; Li-Rong Yu; Mark E Hart; Lauren S Jackson; William H Tolleson
Journal:  Toxins (Basel)       Date:  2022-08-15       Impact factor: 5.075

4.  Metabolic network-based predictions of toxicant-induced metabolite changes in the laboratory rat.

Authors:  Venkat R Pannala; Martha L Wall; Shanea K Estes; Irina Trenary; Tracy P O'Brien; Richard L Printz; Kalyan C Vinnakota; Jaques Reifman; Masakazu Shiota; Jamey D Young; Anders Wallqvist
Journal:  Sci Rep       Date:  2018-08-03       Impact factor: 4.379

5.  Toxicant-Induced Metabolic Alterations in Lipid and Amino Acid Pathways Are Predictive of Acute Liver Toxicity in Rats.

Authors:  Venkat R Pannala; Shanea K Estes; Mohsin Rahim; Irina Trenary; Tracy P O'Brien; Chiyo Shiota; Richard L Printz; Jaques Reifman; Masakazu Shiota; Jamey D Young; Anders Wallqvist
Journal:  Int J Mol Sci       Date:  2020-11-04       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.